Rchr
J-GLOBAL ID:202001014771980721   Update date: Aug. 30, 2021

LI YING-YI

リ エイイ | LI YING-YI
Affiliation and department:
Job title: 研究員
Research field  (2): Virology ,  Tumor biology
Research theme for competitive and other funds  (1):
  • 2018 - 2021 DOCK11ノックダウンによりcccDNA排除の新規抗HBV治療応用への基礎研究
Papers (36):
  • Han Chen, Kouki Nio, Taro Yamashita, Hikari Okada, Ru Li, Tsuyoshi Suda, Yingyi Li, Phuong Thi Bich Doan, Akihiro Seki, Hidetoshi Nakagawa, et al. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma. Molecular oncology. 2021. 15. 8. 2203-2218
  • Yang Li, Zhichao Xi, Xiaoqiong Chen, Shuangfan Cai, Chen Liang, Zhen Wang, Yingyi Li, Hongsheng Tan, Yuanzhi Lao, Hongxi Xu. Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways. Cell death & disease. 2018. 9. 5. 538-538
  • Ting Li, Zhen Wang, Yi-feng Hou, Ying-yi Li. Pim-3 Regulates Stemness of Pancreatic Cancer Cells via Activating STAT3 Signaling Pathway. JOURNAL OF CANCER. 2017. 8. 9. 1530-1541
  • Haiyong Wang, Zhouyu Ning, Yingyi Li, Xiaoyan Zhu, Zhiqiang Meng. Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. MOLECULAR MEDICINE REPORTS. 2016. 14. 3. 1907-1914
  • Xiang-Yuan Chen, Zhen Wang, Bei Li, Ying-Jian Zhang, Ying-Yi Li. Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2016. 473. 1. 296-302
more...
Lectures and oral presentations  (1):
  • Blockade of Pim-3/ASS1 axis confers tumor cell response to arginine deprivation in pancreatic cancer
Association Membership(s) (1):
日本肝臓学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page